The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Trend Is Expected For The Hormonal Intrauterine Devices (IUDs) Market From 2026 To 2030?
The market size for hormonal intrauterine devices (iuds) has expanded significantly in recent years. This market is projected to grow from $2.87 billion in 2025 to $3.18 billion in 2026, at a compound annual growth rate (CAGR) of 10.6%. Historically, this growth can be attributed to heightened awareness regarding family planning options, the expansion of women’s reproductive healthcare programs, a rising preference for long-term contraception, the increasing availability of hormone-based devices, and strong support from public health initiatives.
The market size for hormonal intrauterine devices (iuds) is anticipated to experience significant expansion over the upcoming years. It is projected to reach $4.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.5%. This growth during the forecast period is fueled by factors such as the increasing demand for non-surgical contraceptive alternatives, an elevated focus on menstrual health management, wider access in emerging markets, rising investments in women’s health technologies, and continued innovation in hormone delivery systems. Prominent trends throughout the forecast period include the growing adoption of low-dose hormonal iuds, an increasing need for long-acting reversible contraceptives, a developing preference for frameless device designs, the broadening of therapeutic iud applications, and an intensified emphasis on patient comfort and safety.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp
What Primary Factors Are Fueling The Expansion Of The Hormonal Intrauterine Devices (IUDs) Market?
The growing prevalence of unintended pregnancies is anticipated to drive the expansion of the hormonal intrauterine devices market. Unintended pregnancies are defined as those not planned or desired when conception occurs. Such pregnancies can result from various factors, including contraceptive failures, insufficient access to birth control methods, incorrect use of contraception, or instances of sexual violence. When access to effective contraception is restricted, it escalates the likelihood of unintended pregnancies by diminishing individuals’ autonomy over their reproductive choices. Hormonal IUDs demonstrate high effectiveness in preventing pregnancy, boasting a failure rate of less than 1%. These devices offer sustained protection for 3 to 7 years, depending on the specific type, presenting a reliable option for individuals aiming to prevent unwanted pregnancies. For instance, in July 2025, data from the Society for Family Planning, a professional body based in the US, indicated a rise in abortions to 1.14 million in 2024, up from 1.05 million recorded in 2023. Consequently, the increasing incidence of unwanted pregnancies is a key factor propelling the growth of the hormonal intrauterine devices market.
How Is Segment Classification Applied In The Hormonal Intrauterine Devices (IUDs) Market?
The hormonal intrauterine devices (iuds) market covered in this report is segmented –
1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices
3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications
Subsegments:
1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
What Trends Are Influencing The Future Of The Hormonal Intrauterine Devices (IUDs) Market?
Prominent companies in the hormonal intrauterine devices market are concentrating on developing sophisticated products, such as levonorgestrel intrauterine devices (IUDs), aimed at alleviating menstrual bleeding and cramps. These levonorgestrel intrauterine devices (IUDs) serve as extended-duration birth control solutions, implanted into the uterus to gradually release the hormone levonorgestrel and prevent pregnancy. For example, in October 2024, Medicines360, a nonprofit organization based in the US, introduced Avibela, a 52 mg levonorgestrel intrauterine device (IUD), in Zambia. This device offers two primary benefits: up to eight years of pregnancy avoidance and up to five years of reduction in heavy menstrual bleeding. Its contraceptive action stems from its capacity to increase the density of cervical mucus, thereby stopping sperm from accessing the uterus. For managing heavy bleeding, it functions by thinning the uterine lining, which contributes to a decrease in menstrual flow.
Who Are The Leading Firms Participating In The Hormonal Intrauterine Devices (IUDs) Market?
Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.
Access The Complete Hormonal Intrauterine Devices (IUDs) Market Report:
Which Region Holds The Largest Share In The Hormonal Intrauterine Devices (IUDs) Market?
North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Hormonal Intrauterine Devices (IUDs) Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2026, By The Business Research Company
Contraceptive Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report
Hormonal Contraceptives Market Report 2026
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Gynecological Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/gynecological-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model